The Aff solves – banning use of germline means that equipment and ease of access severely decreases
Barry Pavel and Vikram Venkatram , 21, (Barry Pavel, Barry Pavel is the senior vice president and director of the Scowcroft Center for Strategy and Security at the Atlantic Council. Prior to joining the Atlantic Council, Barry Pavel was a career member of the Senior Executive Service in the Officer of the Under Secretary of Defense for Policy for almost eighteen years. From October 2008 to July 2010, he served as the special assistant to the President and senior director for defense policy and strategy on the National Security Council (NSC) staff, serving both President George W. Bush and President Barack Obama. Prior to this, Pavel was the chief of staff and principal deputy assistant secretary of defense for special operations/low-intensity conflict and interdependent capabilities. From October 1993 to November 2006, Pavel also led or contributed to a broad range of defense strategy and planning initiatives for both the Clinton and George W. Bush administrations. In this capacity, Pavel supported post-9/11 deterrence policy (including deterrence of terrorist networks and regional nuclear powers); strategies for reducing ungoverned areas; and a long-range planning construct that accounts for trends and “strategic shocks” that could significantly change Department of Defense’s role in national security. Vikram Venkatram is a Young Global Professional in the Scowcroft Center for Strategy and Security, Forward Defense at the Atlantic Council. He is a recent graduate of Georgetown University’s School of Foreign Service, where he studied Science, Technology, and International Affairs with a minor in Biology. He is also currently a second-year graduate student in Georgetown’s Security Studies Program. Originally from San Jose, California, his main interests lie in biosecurity issues, ranging from pandemic preparedness to emerging biotechnology to environmental security to bioethics., 9-7-2021, Atlantic Council, Facing the future of bioterrorism, https://www.atlanticcouncil.org/commentary/article/facing-the-future-of-bioterrorism/, 7-1-2022) SCade
However, greater access to cheap but powerful biotechnology tools—and a reduced need for expertise in operating those tools—also is making it easier for malicious actors to utilize that technology for ill. Terrorist groups could use synthetic biology to craft bioweapons, using data to manufacture dangerous pathogens or modifying easily accessible pathogens to make them more virulent. At present, there are still some barriers to entry that prevent such actors from operating with free reign, as widespread access to certain pathogens, tools, and data is still limited. But these barriers will only continue to recede over the next decade. In evaluating the future of terrorism and counterterrorism, one must consider: How should the United States and its allies prepare to face the growing threat of bioterrorism?